Biochemical markers in vascular cognitive impairment associated with subcortical small vessel disease - A consensus report.
Anders WallinE KapakiM BobanS EngelborghsD M HermannB HuisaM JonssonM G KrambergerL LossiB MalojcicS MehrabianA MerighiE B Mukaetova-LadinskaG P ParaskevasB O PopescuR RavidL TraykovG TsivgoulisG WeinsteinA KorczynM BjerkeG RosenbergPublished in: BMC neurology (2017)
Combining SSVD and AD biomarkers may provide a powerful tool to identify with greater precision appropriate patients for clinical trials of more homogeneous dementia populations. Thereby, biomarkers might promote therapeutic progress not only in VCI-SSVD, but also in AD.